1. Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital. Phillips CJ, McKinnon RA, Woodman RJ, Gordon DL. J Infect Chemother. 2017 Oct 13. pii: S1341-321X(17)30213-1. doi: 10.1016/j.jiac.2017.09.010.
2. Trisomy 12 assessment by conventional fluorescence in-situ hybridization (FISH), FISH in suspension (FISH-IS) and laser scanning cytometry (LSC) in chronic lymphocytic leukemia. Do CH, Lower KM, Macardle C, Kuss BJ. Cancer Genet. 2017 Oct;216-217:142-149. doi: 10.1016/j.cancergen.2017.07.009. Epub 2017 Aug 4.
3. Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia. Do CH, Bailey S, Macardle C, Thurgood LA, Lower KM, Kuss BJ. Cytometry A. 2017 Oct 11. doi: 10.1002/cyto.a.23264.
3. Heart failure following blood cancer therapy in pediatric and adult populations. Franzon J, Berry NM, Ullah S, Versace VL, McCarthy AL, Atherton J, Roder D, Koczwara B, Coghlan D, Clark RA. Asia Pac J Clin Oncol. 2017 Oct 12. doi: 10.1111/ajco.12782.
4. Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly. Roder D, Farshid G, Kollias J, Koczwara B, Karapetis C, Adams J, Joshi R, Keefe D, Miller C, Powell K, Fusco K, Eckert M, Buckley E, Beckmann K, Price T.J Eval Clin Pract. 2017 Oct 8. doi: 10.1111/jep.12819.
5. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. Singhal D, Kutyna MM, Chhetri R, Wee LYA, Hague S, Nath L, Nath SV, Sinha R, Wickham N, Lewis ID, Ross DM, Bardy PG, To LB, Reynolds J, Wood EM, Roxby DJ, Hiwase DK. Haematologica. 2017 Oct 5. pii: haematol.2017.175752. doi: 10.3324/haematol.2017.175752.
6. Isolation and Structural Characterization of Echinocystic Acid Triterpenoid Saponins from the Australian Medicinal and Food Plant Acacia ligulata. Jæger D, Ndi CP, Crocoll C, Simpson BS, Khakimov B, Guzman-Genuino RM, Hayball JD, Xing X, Bulone V, Weinstein P, Møller BL, Semple SJ. J Nat Prod. 2017 Oct 4. doi: 10.1021/acs.jnatprod.7b00437.
7. Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia. Latham S, Hughes E, Budgen B, Mechinaud F, Crock C, Ekert H, Campbell P, Morley A. PLoS One. 2017 Oct 3;12(10):e0185556. doi: 10.1371/journal.pone.0185556. eCollection 2017.
8. Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers. Hopkins AM, Rowland A, Kichenadasse G, Wiese MD, Gurney H, McKinnon RA, Karapetis CS, Sorich MJ. Br J Cancer. 2017 Sep 26;117(7):913-920. doi: 10.1038/bjc.2017.274.